MSG may boost gut bacteria compound tied to blood sugar problems

NCT ID NCT07700368

First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time

Summary

This trial investigates whether the common flavor enhancer monosodium glutamate (MSG) increases blood levels of imidazole propionate (ImP), a compound produced by gut bacteria from the amino acid histidine. Higher ImP levels have been linked to blood-sugar control issues. Healthy adult volunteers take L-histidine supplements with either MSG or a salt placebo for one week each, and researchers compare ImP levels in their blood. The study aims to uncover a potential dietary influence on a microbiome-derived compound that may affect metabolic health.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
monosodium glutamate (MSG) and L-histidine dietary supplements
What this could lead to
If MSG raises ImP levels, it could point to a dietary link between MSG and blood-sugar regulation.
What could go wrong
This is a small, early-stage study in healthy volunteers, so results may not apply to the general population or people with health conditions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY ADULT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Duchossois Family Institute, Knapp Center for Biomedical Discovery (KCBD), Room 4214

    Chicago, Illinois, 60637, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.